Amoasii, Leonela
Li, Hui http://orcid.org/0000-0002-4114-8349
Zhang, Yu http://orcid.org/0000-0003-3384-8887
Min, Yi-Li
Sanchez-Ortiz, Efrain
Shelton, John M.
Long, Chengzu
Mireault, Alex A.
Bhattacharyya, Samadrita http://orcid.org/0000-0002-2709-3804
McAnally, John R.
Bassel-Duby, Rhonda
Olson, Eric N.
Funding for this research was provided by:
Foundation for the National Institutes of Health (HL130253, AR067294, U54HD087351)
Article History
Received: 30 July 2018
Accepted: 20 August 2019
First Online: 4 October 2019
Competing interests
: L.A., R.B.D., and E.N.O. are consultants for Exonics Therapeutics. L.A., C.L., R.B.D., and E.N.O. are listed as co-inventors on two filed patents regarding the mouse model (provisional filing application number 62/431,699) and strategy (provisional filing application number 62/442,606) presented in this study. Remaining authors declare no competing interests.